NADROPARIN

Nadroparin is an anticoagulant used to prevent the formation and growth of blood clots in patients with certain specific medical conditions. It is also used to prevent blood clots that may potentially form during certain medical procedures. It is used in combination with aspirin to prevent serious complications associated with angina and heart attacks.

Indications

Nadroparin is indicated in the prevention of thromboembolic disorders, primarily deep vein thrombosis and pulmonary embolism, in general and orthopedic surgery, Nadroparin is indicated in the treatment of unstable angina and non-Q wave myocardial infarction.

Dosage

Adults: The dose is based on body weight. It is usually 86 anti-factor Xa International Units (IU) per kilogram (kg) (39.1 anti-factor Xa IU per pound) of body weight injected under the skin every twelve hours for six days. Children: Use and dose must be determined by your doctor.

Contra-Indications

Contraindicated in patients with history of abnormal decrease in platelet counts, uncontrolled high blood pressure, increased risk of bleeding, peptic ulceration, head injuries, stroke.

Special Precautions

Caution should be exercised in patients undergoing epidural anesthesia, history of heparin-induced platelet defects, increased risk of bleeding, severe liver or kidney disease, any allergy, during pregnancy and breastfeeding.

Side Effects

Deep, dark purple bruise, pain, or swelling at place of injection

Drug Interactions

Nadroparin exactly as instructed by the doctor. It should not be injected into the muscles. It is advised to administer this medicine under the supervision of a doctor in a clinical setup with regular monitoring of blood clotting time and other related parameters. Your doctor may ask you to undergo certain tests to determine the safety of use of this medicine.